Press Release: Innora GmbH and WeMed Technologies Forge Strategic Partnership

Berlin, September 30, 2024 — Innora GmbH and WeMed Technologies are pleased to announce that they have entered into a strategic partnership aimed at bringing innovations to the field of peripheral vascular devices. This collaboration will focus on developing a Drug Transfer Balloon Catheter System (DTB) for targeted drug delivery within the vasculature.

Through this partnership, Innora GmbH will provide its expertise and resources to support the development of WeMed Technologies’ DTB system. The shared goal is to create a next-generation medical device that enables more effective treatment of vascular diseases and meets the evolving needs of the healthcare sector.

Dr. Thomas Speck, CEO of Innora GmbH, stated, "This collaboration represents a significant step in advancing targeted drug delivery technology for vascular treatments." Ahmet Alnidelik, Founder and CEO of WeMed Technologies, added, "This partnership will accelerate the development process of our DTB system and help us bring this innovative device to market more efficiently."

We plan to announce the initial results of the project within the coming year.

About Innora GmbH:

Innora GmbH is a leading medical technology company specializing in the research, development, and commercialization of innovative vascular therapies. With extensive experience in drug transfer, formulation, and medical device design, the company focuses on developing solutions that address critical needs in vascular health. Innora GmbH is committed to advancing targeted drug transfer systems and setting new standards in the industry. By combining cutting-edge research with practical clinical applications, the company continues to pioneer breakthroughs in medical technology.

About WeMed Technologies:

WeMed Technologies is a start-up specializing in developing innovative peripheral vascular devices, with a particular focus on endovascular applications and targeted drug delivery. Driven by a mission to revolutionize vascular treatments, WeMed aims to introduce groundbreaking solutions that enable more effective treatment of vascular diseases and meet the demands of modern medicine.

TOP